IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 184 filers reported holding IMPAX LABORATORIES INC in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $203,000 | -48.6% | 9,984 | -27.2% | 0.01% | -50.0% |
Q2 2016 | $395,000 | -18.6% | 13,718 | -25.3% | 0.02% | +23.1% |
Q1 2014 | $485,000 | +84.4% | 18,363 | +75.8% | 0.01% | +62.5% |
Q4 2013 | $263,000 | -23.3% | 10,446 | -37.6% | 0.01% | -20.0% |
Q3 2013 | $343,000 | – | 16,743 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |